Explore the Global Breast Cancer Diagnostics Market— analysis of key trends, regional growth, top players, and a 10-year forecast from 2026 to 2036.

Future Market Insights

Breast Cancer Diagnostics Market

Key Insight

Breast cancer diagnostics sales will expand through 2036, with imaging holding 52% of the type outlook segment in 2026. The market was valued at USD 6.52 billion in 2025 and is expected to be worth USD 14.87 billion by 2036, creating an incremental opportunity of USD 10.18 billion.

May 15, 2026

Anurag Sharma

250 Pages

Cite this Report

Breast Cancer Diagnostics Market

https://www.futuremarketinsights.com/reports/breast-cancer-diagnostics-market

License

Buy Now

Summary ToC Infographics Companies

Key Players

Argon Medical Devices
T. Rowe Price
F. Hoffmann-La Roche Ag
Genomic Health (Exact Sciences Corporation)
Hologic
Koninklijke Philips NV
Myriad Genetics
Qiagen
Thermo Fisher Scientific Inc.

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Breast Cancer Diagnostics Market

Key Players

Similar Industry Reports